Oramed Pharmaceuticals Inc logo

Oramed Pharmaceuticals Inc

$ 6.74 +0.12 (+1.81%) 10:08 PM EST
P/E:
At Loss
P/B:
1.69
Market Cap:
$ 261.69M
Enterprise V:
$ 124.10M
Volume:
254.91K
Avg Vol (2M):
359.53K
Also Trade In:
Volume:
254.91K
Market Cap $:
261.69M
PE Ratio:
At Loss
Avg Vol (2-Month):
359.53K
Enterprise Value $:
124.10M
PB Ratio:
1.69
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Oramed Pharmaceuticals Inc is a pharmaceutical company which is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The ORMD-0801 is a proprietary product which is an orally ingestible insulin capsule for the treatment of diabetes. Its other product includes Oral Glucagon-like peptide-1 which is an incretin hormone, a type of gastrointestinal hormone that stimulates the secretion of insulin from the pancreas.
Name Current Vs Industry Vs History
Cash-To-Debt 137.06
Equity-to-Asset 0.95
Debt-to-Equity 0.01
Debt-to-EBITDA -0.03
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 15.62
Distress
Grey
Safe
Beneish M-Score -2.47
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 29.17
9-Day RSI 31.2
14-Day RSI 36.07
6-1 Month Momentum % -7.27
12-1 Month Momentum % -62.86

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 21.01
Quick Ratio 21.01
Cash Ratio 20.87

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -26.7

Financials (Next Earnings Date:2023-01-11 Est.)

ORMP's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ORMP

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 2.697
EPS (TTM) ($) -0.97
Beta 2.54
Volatility % 119.7
14-Day RSI 36.07
14-Day ATR ($) 0.550024
20-Day SMA ($) 7.7325
12-1 Month Momentum % -62.86
52-Week Range ($) 3.59 - 31.54
Shares Outstanding (Mil) 38.83

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Oramed Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Oramed Pharmaceuticals Inc Analysis

Share your research

Headlines

See More
No news.